Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease

(2014) Valerio Nobili et al.   PLoS One

The Western Dietary Pattern Is Prospectively Associated With Nonalcoholic Fatty Liver Disease in Adolescence

(2013) Wendy H Oddy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gut microbiota and non-alcoholic fatty liver disease: new insights

(2013) J. Aron-Wisnewsky et al.   CLINICAL MICROBIOLOGY AND INFECTION

Weight control, endocrine hormones and cancer prevention

(2013) Brenee King et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus

(2013) Daisuke Suzuki et al.   INTERNAL MEDICINE

Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion

(2013) Hariom Yadav et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: Effect of dietary methyl donor supplementation

(2013) Paul Cordero et al.   MOLECULAR GENETICS AND METABOLISM

The Gordian Knot of dysbiosis, obesity and NAFLD

(2013) Wajahat Z. Mehal   Nature Reviews Gastroenterology & Hepatology

The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity

(2013) Aaron S. Kelly et al.   JAMA Pediatrics

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes

(2013) Baptist Gallwitz   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies

(2012) Otilia E. Frasinariu et al.   DIGESTIVE AND LIVER DISEASE

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

(2012) Lixin Zhu et al.   HEPATOLOGY

A 360-degree overview of paediatric NAFLD: Recent insights

(2012) Valerio Nobili et al.   JOURNAL OF HEPATOLOGY

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach

(2012) Anna Alisi et al.   Nature Reviews Gastroenterology & Hepatology

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

(2012) D. Compare et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children

(2012) V. Nobili et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

(2012) Andrea Mencarelli et al.   PLoS One

Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease

(2012) Kirsty Brown et al.   Nutrients

GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

(2012) Jinmi Lee et al.   Diabetes & Metabolism Journal

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

(2011) Anna Alisi et al.   ANNALS OF MEDICINE

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

(2011) V. Nobili et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

(2011) N. Vazzana et al.   CURRENT MEDICINAL CHEMISTRY

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2011) Joel E. Lavine   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms

(2011) Anna Iacono et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

(2011) Pietro Vajro et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Probiotics Modulate Intestinal Expression of Nuclear Receptor and Provide Counter-Regulatory Signals to Inflammation-Driven Adipose Tissue Activation

(2011) Andrea Mencarelli et al.   PLoS One

Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency

(2010) Melanie D. Spencer et al.   GASTROENTEROLOGY

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice

(2009) Arumugam Velayudham et al.   HEPATOLOGY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Pediatric non-alcoholic fatty liver disease: Preventive andtherapeutic value of lifestyle intervention

(2009) Valerio Nobili et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study

(2008) V NOBILI et al.   CLINICAL THERAPEUTICS

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial

(2008) Valerio Nobili et al.   HEPATOLOGY

High Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity: A Contributor to Severe Hepatic Steatosis

(2008) Jean-Marc Sabaté et al.   OBESITY SURGERY